Diabetic neuropathy
Conditions
Interventions
The intervention deals with the applicability of laser therapy in 12 sessions over 23 days of TLBI (Low Intensity Laser Therapy) and ILBI (Intravascular Laser Irradiation of Blood), with an interval o
E02.594
Sponsors
Universidade da Integração Internacional da Lusofonia Afro-Brasileira
Universidade da Integração Internacional da Lusofonia Afro-Brasileira
Eligibility
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Having type I or type II DM with diabetic peripheral neuropathy; presenting sensory alterations; reporting burning pain with paresthesia in one or both lower extremities; being aged between 30 and 70 years
Exclusion criteria
Exclusion criteria: Have foot ulcers; have serious complications of diabetes mellitus (target organ damage, diabetic ketoacidosis, hypoglycemia and chronic cardiovascular diseases); have neurological deficiencies not associated with diabetes; have thyroid dysfunction; be pregnant, have a metal implant in the body; abuse drugs; have cancer; and to use a wheelchair
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find an improvement in tactile, painful and thermal sensitivity in feet of patients with diabetes mellitus after implementing low-intensity laser therapy and intravascular laser blood irradiation, in 12 sessions over 23 days. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to observe whether the Michigan Neuropathy Screening Instrument is effective for neuropathic screening of patients with diabetes mellitus who require the joint applicability of low-intensity laser therapy and intravascular laser blood irradiation. | — |
Countries
Brazil
Contacts
Public ContactJoelita Santos
Universidade da Integração Internacional da Lusofonia Afro-Brasileira
Outcome results
None listed